Solventum (MEX:SOLV) Change In Receivables: MXN-2,892 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:SOLV Solventum Corp MEX:SOLV
22 GF Score
Price MXN1,382.00
! 7 Warning Signs
View Full Analysis

What is Solventum Change In Receivables?

Solventum MEX:SOLV 22 Change In Receivables is MXN-2,892 Mil as of Jun. 2026. GuruFocus rates MEX:SOLV with a GF Score™ of 22/100. The stock has 7 warning signs investors should review.

Solventum's change in receivables for the quarter that ended in Jun. 2026 was MXN-4,415 Mil. It means Solventum's Accounts Receivable increased by MXN4,415 Mil from Mar. 2026 to Jun. 2026 .

Solventum's change in receivables for the fiscal year that ended in Dec. 2025 was MXN1,404 Mil. It means Solventum's Accounts Receivable declined by MXN1,404 Mil from Dec. 2024 to Dec. 2025 .

Solventum's Accounts Receivable for the quarter that ended in Jun. 2026 was MXN22,858 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Solventum's Days Sales Outstanding for the three months ended in Jun. 2026 was 54.11.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Solventum's liquidation value for the three months ended in Jun. 2026 was MXN-131,539 Mil.

Solventum  (MEX:SOLV) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Solventum's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=22858.19/38544.841*91
=54.11

2. In Ben Graham's calculation of liquidation value, Solventum's accounts receivable are only considered to be worth 75% of book value:

Solventum's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=7031.947-164788.356+0.75 * 22858.19+0.5 * 18146.96
=-131,539

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solventum Change In Receivables Related Terms

Solventum Change In Receivables Historical Data

* Premium members only.

The historical data trend for Solventum's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solventum Change In Receivables Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial -20.51 -623.87 -2,189.68 5,756.17 1,404.45

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -414.24 1,540.91 90.03 -108.20 -4,414.60
MEX:SOLV
22GF Score
Solventum Corp MEX:SOLV
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solventum Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-2,892 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of MXN-2,892 Mil mean?
Solventum (MEX:SOLV) has a Change In Receivables of MXN-2,892 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Solventum and its competitors.
Is Solventum's Change In Receivables too high?
Solventum's current Change In Receivables is MXN-2,892 Mil. Overall, Solventum has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's Change In Receivables compare to COO and ALGN?
Solventum's Change In Receivables of MXN-2,892 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Solventum and its competitors. Solventum's current Change In Receivables is MXN-2,892 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (MEX:SOLV) has a current Change In Receivables of MXN-2,892 Mil. The current Change In Receivables is MXN-2,892 Mil. Solventum's overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Solventum (MEX:SOLV), the current Change In Receivables is MXN-2,892 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solventum Business Description

Address 2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
22GF Score

Get the complete analysis for MEX:SOLV

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,382.00
Price